Browsing Centre for Clinical Trials & Methodology by Author "Chan, CL"
Now showing items 1-4 of 4
-
Assessing the transparency of informed consent in feasibility and pilot studies: a single-centre quality assurance study protocol
Khan, MI; Holek, M; Bdair, F; Mbuagbaw, L; Eldridge, SM; Chan, CL; Campbell, MJ; Bond, CM; Hopewell, S; Lancaster, GA (2020) -
Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review
Turner, EL; Platt, AC; Gallis, JA; Tetreault, K; Easter, C; McKenzie, JE; Nash, S; Forbes, AB; Hemming, K; Group, CBOR (Elsevier, 2021-08-01) -
Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
Chan, CL; Taljaard, M; Lancaster, GA; Brehaut, JC; Eldridge, SM (2021-07-03)BACKGROUND AND OBJECTIVE: Feasibility studies are increasingly being used to support the development of, and investigate uncertainties around, future large-scale trials. The future trial can be designed with either a ... -
Transparency of informed consent in pilot and feasibility studies is inadequate: a single-center quality assurance study.
Khan, MIU; Mbuagbaw, L; Holek, M; Bdair, F; Durrani, ZH; Mellor, K; Eddy, S; Eldridge, SM; Chan, CL; Campbell, MJ (BioMed Central, 2021-04-16)BACKGROUND: Pilot and feasibility studies (PAFS) often have complex objectives aimed at assessing feasibility of conducting a larger study. These may not be clear to participants in pilot studies. METHODS: Here, we aimed ...